Inspire Veterinary Partners Announces Phillip Balatsos as New Independent Nominee for Election to Board of Directors
Inspire Veterinary Partners (Nasdaq: IVP) has nominated Phillip Balatsos as a new independent director for election at its annual stockholders meeting on October 9, 2024. Balatsos, currently Vice President of Foreign Exchange Emerging Markets Rates Sales/Trading at XP Investments US Inc., brings a diverse background in finance, hospitality, and public company board experience. His nomination aims to provide valuable perspectives for Inspire's strategic growth objectives.
Larry Alexander, Chair of the Nominating and Corporate Governance Committee, expressed confidence in Balatsos' potential contributions. Balatsos himself stated his alignment with Inspire's mission to improve pet lives and his eagerness to contribute to the company's future growth and success.
Inspire Veterinary Partners (Nasdaq: IVP) ha nominato Phillip Balatsos come nuovo direttore indipendente per l'elezione durante l'assemblea annuale degli azionisti che si terrà il 9 ottobre 2024. Balatsos, attualmente Vice Presidente delle Vendite/Negoziati sui tassi di cambio nei mercati emergenti presso XP Investments US Inc., porta con sé un background variegato in finanza, ospitalità e esperienza in consigli di amministrazione di società pubbliche. La sua nomina mira a fornire prospettive preziose per gli obiettivi di crescita strategica di Inspire.
Larry Alexander, Presidente del Comitato per le Nomine e la Governance Aziendale, ha espresso fiducia nelle potenziali contribuzioni di Balatsos. Lo stesso Balatsos ha dichiarato di essere allineato con la missione di Inspire nel migliorare la vita degli animali domestici e la sua disponibilità a contribuire alla crescita e al successo futuro dell'azienda.
Inspire Veterinary Partners (Nasdaq: IVP) ha nominado a Phillip Balatsos como nuevo director independiente para su elección en la reunión anual de accionistas que se llevará a cabo el 9 de octubre de 2024. Balatsos, actualmente Vicepresidente de Ventas/Comercio de Tipos de Cambio en Mercados Emergentes en XP Investments US Inc., aporta una experiencia diversa en finanzas, hospitalidad y en juntas directivas de empresas públicas. Su nominación tiene como objetivo proporcionar perspectivas valiosas para los objetivos de crecimiento estratégico de Inspire.
Larry Alexander, Presidente del Comité de Nominaciones y Gobernanza Corporativa, expresó confianza en las posibles contribuciones de Balatsos. El propio Balatsos declaró que está alineado con la misión de Inspire de mejorar la vida de las mascotas y su deseo de contribuir al crecimiento y éxito futuros de la empresa.
인스파이어 베테리너리 파트너스(Nasdaq: IVP)는 필립 발라초스를 2024년 10월 9일에 열리는 연례 주주 총회에서 선출할 새로운 독립 이사로 지명했습니다. 발라초스는 현재 XP Investments US Inc.의 외환 신흥 시장 금리 영업/거래 부사장으로 활동하고 있으며, 금융, 호텔업, 공공 기업 이사회 경영의 다양한 배경을 가지고 있습니다. 그의 지명은 인스파이어의 전략적 성장 목표를 위해 가치 있는 관점을 제공하는 것을 목표로 하고 있습니다.
론 알렉산더, 지명 및 기업 거버넌스 위원회의 의장은 발라초스의 기여 가능성에 대한 확신을 표현했습니다. 발라초스는 인스파이어의 반려동물 생명 개선 미션과 일치하며, 회사의 미래 성장과 성공에 기여하고 싶다는 열망을 밝혔습니다.
Inspire Veterinary Partners (Nasdaq: IVP) a nommé Phillip Balatsos en tant que nouveau directeur indépendant à élire lors de son assemblée annuelle des actionnaires qui se tiendra le 9 octobre 2024. Balatsos, actuellement vice-président des ventes/négociations sur les taux de change dans les marchés émergents chez XP Investments US Inc., apporte un parcours diversifié en finance, hôtellerie et expérience au sein de conseils d'administration d'entreprises publiques. Sa nomination vise à fournir des perspectives précieuses pour les objectifs de croissance stratégique d'Inspire.
Larry Alexander, président du Comité des nominations et de la gouvernance d'entreprise, a exprimé sa confiance dans les contributions potentielles de Balatsos. Balatsos lui-même a déclaré qu'il était en accord avec la mission d'Inspire d'améliorer la vie des animaux de compagnie et sa volonté de contribuer à la croissance et au succès futurs de l'entreprise.
Inspire Veterinary Partners (Nasdaq: IVP) hat Phillip Balatsos als neuen unabhängigen Direktor zur Wahl auf der jährlichen Hauptversammlung der Aktionäre am 9. Oktober 2024 nominiert. Balatsos, der derzeit als Vizepräsident für Devisenverkäufe/Handel in Schwellenländern bei XP Investments US Inc. tätig ist, bringt einen vielfältigen Hintergrund in den Bereichen Finanzen, Gastgewerbe und Erfahrung in öffentlichen Unternehmensvorständen mit. Seine Nominierung zielt darauf ab, wertvolle Perspektiven für die strategischen Wachstumsziele von Inspire zu bieten.
Larry Alexander, Vorsitzender des Nominierungs- und Corporate Governance-Ausschusses, äußerte Vertrauen in Balatsos' potenzielle Beiträge. Balatsos selbst erklärte, dass er mit der Mission von Inspire, das Leben von Haustieren zu verbessern, übereinstimmt und er bereit ist, zur zukünftigen Wachstums- und Erfolgsgeschichte des Unternehmens beizutragen.
- Nomination of an experienced independent director with diverse background in finance and public company governance
- Potential for fresh perspectives and valuable insights to support strategic growth objectives
- Alignment of nominee's interests with company's mission to improve pet lives
- None.
VIRGINIA BEACH, VA / ACCESSWIRE / August 16, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that its board of directors has nominated Phillip Balatsos to stand for election as an independent director at its annual meeting of stockholders on October 9, 2024.
Mr. Balatsos has served as the Vice President of Foreign Exchange Emerging Markets Rates Sales/Trading with XP Investments US Inc. since August 2022. Mr. Balatsos provides coverage and execution of currency trading in emerging markets as well as commodity and fixed income products and derivatives for global macro hedge funds. In September of 2018 Mr. Balatsos founded LAPH Hospitality where he served as an Operator until August of 2022. During his time with LAPH Hospitality, Mr. Balatsos operated a multi-location café/catering business. Mr. Balatsos previously served as a director member on the board for Sadot Group Inc. and served on the audit and finance committees during his term. Prior to his tenure in hospitality, Mr. Balatsos held various positions on Wall Street including Vice President, Foreign Exchange Sales/Trading for Credit Suisse; Director, Foreign Exchange Hedge Fund Sales for Barclays Capital, and Financial Advisor for Stifel Nicolaus & Co.
Larry Alexander, Inspire's Independent Director and Chair of the Nominating, and Corporate Governance Committee, said, "We are pleased to nominate Phillip Balatsos to serve on Inspire's board of directors. We look forward to his future contributions and believe his experience serving as a director of a public company, combined with a strong operational, sales and financial background will provide valuable perspectives for our Board of Directors as Inspire continues to execute on its strategic growth objectives over the next several years."
"I am excited and honored to be nominated to join Inspire's Board of Directors," said Phillip Balatsos. "Inspire's commitment to provide trusted services that improve pet lives is a mission that aligns with my interests, and I see a tremendous opportunity for future growth. I look forward to collaborating with the board and management team to further the company's strategic vision and contribute to its continued success and growth."
About Inspire Veterinary Partners, Inc.
Inspire Veterinary Partners is an owner/operator of veterinary hospitals in the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care.
For more information, please visit: www.inspirevet.com.
Connect with Inspire Veterinary Partners, Inc.
Facebook
https://www.facebook.com/InspireVeterinaryPartners/
LinkedIn
https://www.linkedin.com/company/inspire-veterinary-partners/
Forward-Looking Statements
This press release contains forward-looking statements regarding the Company's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the satisfaction of customary closing conditions related to anticipated acquisitions, or factors that result in changes to the Company's anticipated results of operations related to acquisitions. These and other risks and uncertainties are described more fully in the section captioned "Risk Factors" in the Company's public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.
Investor Contact
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com
General Inquires
Morgan Wood
Mwood@inspirevet.com
SOURCE: Inspire Veterinary Partners, Inc.
View the original press release on accesswire.com
FAQ
Who is Phillip Balatsos and why was he nominated to Inspire Veterinary Partners' board?
When is Inspire Veterinary Partners' (IVP) annual stockholders meeting scheduled for 2024?
What is Phillip Balatsos' current role and background?
How does Phillip Balatsos' nomination align with Inspire Veterinary Partners' (IVP) goals?
